Benzinga | Mar 2, 2021 07:36AM EST

Neuronetics Q4 EPS $(0.19) Beats $(0.24) Estimate, Sales $15.60M Beat $14.40M Estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 53.66 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $15.60 million which beat the analyst consensus estimate of $14.40 million by 8.33 percent. This is a 10.14 percent decrease over sales of $17.36 million the same period last year.